Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the efficacy of three different long-term treatment strategies of reflux disease in primary care setting.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Antacids; Esomeprazole

Criteria

Inclusion Criteria:

• Subjects who seek medical advice in primary care for symptoms thought to be GERD related (GERD is a condition which develops when the reflux of stomach content causes troublesome symptoms and / or complications).

Exclusion Criteria:

• Subjects with any clinical GERD treatment (PPI, H2-receptor antagonists) within the last 3 months prior to Visit 1.

• A history of severe esophagitis or known other complications, with alarm symptoms